Insights

Strategic partnerships Nuo Therapeutics has a recent exclusive distribution agreement with Smith & Nephew to market the CENTRIO PRP System in the United States, highlighting an opportunity to cross-sell or co-sell complementary wound care and regenerative medicine solutions to joint venture partners, hospitals, and specialty clinics.

Clinical impact Aurix leverages patient-derived platelets and plasma to stimulate healing across chronic wounds such as diabetic foot ulcers and venous leg ulcers, signaling a strong value proposition for wound care centers, wound clinics, and vascular/diabetes programs seeking regenerative, point-of-care therapies.

Sales leadership Recent hiring of a seasoned orthobiologics sales leader with a track record of generating over fifty million in annual revenue and building a large representative network indicates readiness to scale field force, create new territory coverage, and accelerate product adoption across orthopedic and sports medicine markets.

Financial runway The company demonstrates solid funding and revenue visibility with multi-million dollar revenue range and substantial funding backing, suggesting capacity to support go-to-market investments, clinical education programs, and payer engagement to expand reimbursement for biodynamic therapies.

Channel readiness Strategic partnerships, private-label distribution, and a biospecific wound care portfolio position Nuo to pursue hospital system, integrated delivery networks, and specialty clinics as key channels, while leveraging existing tech stack and cloud-based infrastructure to support scalable e-commerce, sales enablement, and customer education.

Similar companies to Nuo Therapeutics, Inc.

Nuo Therapeutics, Inc. Tech Stack

Nuo Therapeutics, Inc. uses 8 technology products and services including WordPress Super Cache, WordPress, MySQL, and more. Explore Nuo Therapeutics, Inc.'s tech stack below.

Media & News

Nuo Therapeutics, Inc.'s Email Address Formats

Nuo Therapeutics, Inc. uses at least 2 email formats:
Nuo Therapeutics, Inc. Email FormatsExamplePercentage
FLast@nuot.comJDoe@nuot.com
81%
Last@nuot.comDoe@nuot.com
19%

Frequently Asked Questions

What is Nuo Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Nuo Therapeutics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Nuo Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Nuo Therapeutics, Inc.'s official website is nuot.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Nuo Therapeutics, Inc. generate?

Minus sign iconPlus sign icon
As of November 2026, Nuo Therapeutics, Inc.'s annual revenue is estimated to be $1M - $10M.

What is Nuo Therapeutics, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Nuo Therapeutics, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Nuo Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of November 2026, Nuo Therapeutics, Inc. has approximately 21 employees across 2 continents, including North America and Europe. Key team members include Ceo/Cfo: D. J., Cso: P. C. and Chief Financial Officer: A. M. Explore Nuo Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Nuo Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Nuo Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Nuo Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Nuo Therapeutics, Inc.'s tech stack includes WordPress Super Cache, WordPress, MySQL, Shopify, Microsoft 365, Google Cloud, Lightbox and WP Engine.

What is Nuo Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Nuo Therapeutics, Inc.'s email format typically follows the pattern of FLast@nuot.com. Find more Nuo Therapeutics, Inc. email formats with LeadIQ.

How much funding has Nuo Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of November 2026, Nuo Therapeutics, Inc. has raised $158M in funding. The last funding round occurred on Jan 21, 2026 for $791K.

When was Nuo Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
Nuo Therapeutics, Inc. was founded in 2001.
Nuo Therapeutics, Inc. logo

Nuo Therapeutics, Inc.

Biotechnology ResearchTexas, United States11-50 Employees

Nuo Therapeutics, Inc. is a biotechnology company based in Houston, Texas, focused on developing and commercializing individualized wound care therapies that leverage a patient’s innate regenerative abilities to promote healing. Its flagship product, Aurix, is a biodynamic hematogel derived from a patient’s own platelets and plasma, used at the point of care to stimulate healing in chronic wounds such as diabetic foot ulcers, venous leg ulcers, and pressure injuries. The approach emphasizes autologous materials to engage the body’s natural repair processes at the wound site.

The company’s customers are clinicians and healthcare providers who treat chronic wounds, seeking therapies that may improve healing outcomes by utilizing the patient’s biology. A notable recent development is an exclusive private label distribution agreement with Smith+Nephew to market the CENTRIO PRP System in the United States. This move places Nuo within the commercial-stage biotechnology and medical device space and reflects a strategy to expand access through partnerships.

Section iconCompany Overview

Phone number
Website
nuot.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2001
Employees
11-50

Section iconFunding & Financials

  • $158M

    Nuo Therapeutics, Inc. has raised a total of $158M of funding over 17 rounds. Their latest funding round was raised on Jan 21, 2026 in the amount of $791K as a Post IPO Debt.

  • $1M - $10M

    Nuo Therapeutics, Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.